Stockscreener 앱 받기
152.76
0.26%
0.22
전일 마감가:
$152.98
열려 있는:
$154.13
하루 거래량:
46,492
Relative Volume:
0.06
시가총액:
$17.07B
수익:
$9.54B
순이익/손실:
$841.00M
주가수익비율:
20.53
EPS:
7.44
순현금흐름:
$1.02B
1주 성능:
-0.42%
1개월 성능:
-1.04%
6개월 성능:
+6.08%
1년 성능:
+13.37%
1일 변동 폭
$152.78
$154.44
1주일 범위
$150.41
$155.45
52주 변동 폭
$123.04
$165.32
퀘스트 다이아그노스틱스 Stock (DGX) Company Profile
명칭
Quest Diagnostics Inc
전화
(973) 520-2700
주소
500 PLAZA DRIVE, SECAUCUS
DGX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
152.78 | 17.07B | 9.54B | 841.00M | 1.02B | 7.44 |
|
TMO
Thermo Fisher Scientific Inc
|
560.87 | 213.05B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
240.71 | 171.63B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
146.03 | 40.96B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
198.37 | 35.93B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
429.65 | 34.28B | 3.84B | 866.24M | 792.60M | 10.37 |
퀘스트 다이아그노스틱스 Stock (DGX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-06 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-12-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | 재개 | Jefferies | Buy |
| 2024-10-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-08-28 | 재개 | Evercore ISI | In-line |
| 2024-07-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2023-12-12 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-06-29 | 개시 | Piper Sandler | Neutral |
| 2023-05-02 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-04-03 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-01-23 | 개시 | Evercore ISI | In-line |
| 2022-11-17 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-08-22 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-04-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-02-23 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-02-02 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-01-28 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2021-05-04 | 업그레이드 | UBS | Neutral → Buy |
| 2021-03-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-10-21 | 업그레이드 | Argus | Hold → Buy |
| 2020-07-29 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-14 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-06-09 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2020-06-02 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2020-04-28 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-27 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-04-27 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2020-03-27 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-08 | 개시 | Wells Fargo | Underweight |
| 2020-01-07 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-12-19 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-07-15 | 다운그레이드 | Goldman | Neutral → Sell |
| 2019-04-02 | 업그레이드 | Jefferies | Hold → Buy |
| 2019-03-18 | 재개 | Credit Suisse | Neutral |
| 2019-01-31 | 다운그레이드 | Argus | Buy → Hold |
| 2019-01-17 | 개시 | UBS | Neutral |
| 2019-01-03 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2018-11-30 | 다운그레이드 | Goldman | Buy → Neutral |
모두보기
퀘스트 다이아그노스틱스 주식(DGX)의 최신 뉴스
Earnings Preview: What to Expect From Quest Diagnostics' Report - TradingView
Oak Thistle LLC Acquires 5,653 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics (NYSE:DGX) Downgraded by StockNews.com to "Hold" - MarketBeat
Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Clean Yield Group Purchases 3,983 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Relationship Genetic Tests Market Report 2024, Featuring - GlobeNewswire
Relationship Genetic Tests Market Report 2024, Featuring Profiles of Laboratory Corporation of America, Quest Diagnostics, Cleveland Clinic, Myriad Genetics, Invitae and More - Yahoo Finance
Zacks Research Has Bullish Outlook for DGX FY2025 Earnings - MarketBeat
Ex-Dividend Reminder: Universal Corp, Shoe Carnival and Quest Diagnostics - Nasdaq
Alzheimer's Disease Diagnostics Research Report 2024-2034: Global Market to Reach $27.87 Billion - GlobeNewswire Inc.
Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Quest Diagnostics Employee Shares How Music Career Led to Healthcare Logistics Success - StockTitan
Quest Diagnostics Strengthens Leadership Team with Chief Quality Officer Appointment - StockTitan
Nordea Investment Management AB Sells 13,456 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch
Quest Diagnostics (NYSE:DGX) Stock Rating Upgraded by Leerink Partnrs - MarketBeat
Quest Diagnostics Inc. stock rises Monday, still underperforms market - MarketWatch
Leerink Partners Upgrades Quest Diagnostics (DGX) - MSN
Quest Diagnostics (NYSE:DGX) Upgraded to "Outperform" at Leerink Partners - MarketBeat
Quest Diagnostics upgraded by Leerink Partners with a new price target - Quantisnow
Quest Diagnostics (NYSE:DGX) shareholders have earned a 9.4% CAGR over the last five years - Simply Wall St
Quest Diagnostics Inc. stock rises Friday, still underperforms market - MarketWatch
Why Quest Diagnostics (DGX) is Poised to Beat Earnings Estimates Again - Yahoo Finance
OhioHealth outsourcing some lab work to Quest Diagnostics - The Business Journals
Quest Diagnostics to Release Fourth Quarter and Full Year 2024 Financial Results on January 30, 2025 - Longview News-Journal
Quest Diagnostics to Report Q4 and Full Year 2024 Results on January 30 Before Market Open - StockTitan
Quest Diagnostics Inc. stock outperforms competitors despite losses on the day - MarketWatch
Should You Hold Quest Diagnostics Stock in Your Portfolio Now? - MSN
How Is Quest Diagnostics' Stock Performance Compared to Other Diagnostics & Research Stocks? - MSN
How Is The Market Feeling About Quest Diagnostics? - Benzinga
Short Interest in Quest Diagnostics Incorporated (NYSE:DGX) Declines By 6.4% - MarketBeat
JPMorgan Chase & Co. Sells 18,505 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Lobbying Update: QUEST DIAGNOSTICS INCORPORATED just disclosed $80,000 of lobbying spending - Nasdaq
Quest Diagnostics Incorporated (NYSE:DGX) Receives $169.15 Average PT from Brokerages - MarketBeat
Quest Diagnostics Inc. stock underperforms Friday when compared to competitors - MarketWatch
Quest Diagnostics Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Quest Diagnostics Inc. stock rises Tuesday, still underperforms market - MarketWatch
Quest Diagnostics Unveils Ambitious ESG Goals in 2023 Corporate Responsibility Report - StockTitan
Franklin Resources Inc. Acquires 17,240 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Principal Financial Group Inc. Grows Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Tidal Investments LLC Has $679,000 Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
StockNews.com Upgrades Quest Diagnostics (NYSE:DGX) to "Buy" - MarketBeat
Quest Diagnostics (NYSE:DGX) Stock Quotes, Forecast and News Summary - Benzinga
Quest Diagnostics to Speak at the 7th Annual Evercore HealthCONx Conference - The Eastern Progress Online
August 2025 Options Now Available For Quest Diagnostics (DGX) - Nasdaq
Quest Diagnostics Launches Health Coaching on questhealth.com to Help Individuals Take Control of Their Health - The Eastern Progress Online
Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test - Yahoo Finance
Mainz Biomed N.V. Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test - Marketscreener.com
Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Sanctuary Advisors LLC Raises Stock Position in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
퀘스트 다이아그노스틱스 (DGX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.97%
자본화:
|
볼륨(24시간):